A detailed history of Ci Private Wealth, LLC transactions in Krystal Biotech, Inc. stock. As of the latest transaction made, Ci Private Wealth, LLC holds 65,000 shares of KRYS stock, worth $12.3 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
65,000
Previous 35,972 80.7%
Holding current value
$12.3 Million
Previous $6.4 Million 86.5%
% of portfolio
0.02%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$153.12 - $183.64 $4.44 Million - $5.33 Million
29,028 Added 80.7%
65,000 $11.9 Million
Q1 2024

May 09, 2024

BUY
$108.01 - $179.35 $3.89 Million - $6.45 Million
35,972 New
35,972 $6.4 Million

Others Institutions Holding KRYS

About Krystal Biotech, Inc.


  • Ticker KRYS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,664,300
  • Market Cap $4.86B
  • Description
  • Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...
More about KRYS
Track This Portfolio

Track Ci Private Wealth, LLC Portfolio

Follow Ci Private Wealth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ci Private Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ci Private Wealth, LLC with notifications on news.